Froelich, Matthias F <br/><br/>
CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.  [electronic resource] 

 -  European radiology  Dec 2018 
 - 5284-5292 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-1084 
<br/><br/><label>Standard No.: </label>10.1007/s00330-018-5454-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Colorectal Neoplasms--diagnosis<br/>Female<br/>Germany--epidemiology<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Prognosis<br/>Prospective Studies<br/>Survival Rate--trends<br/>Tomography, X-Ray Computed--methods